Image

DIVERSITY IN THE TUMOR GENOME AND MICROENVIRONMENT AS DRIVERS OF DCIS PROGRESSION

Investigating Recurrence of Invasive Cancer in Ductal Carcinoma In Situ (DCIS) Patients

Recruiting
100 years and younger
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates ductal carcinoma in situ (DCIS), a condition where abnormal cells are found in the lining of a breast duct. The purpose of the study is to compare cases of DCIS that either did or did not recur as invasive cancer.

Participants will undergo various study procedures to collect data on DCIS cases and their outcomes. The study aims to understand the factors contributing to whether DCIS recurs as invasive cancer.

  • Who can participate: Individuals aged 18 and older with a history of ductal carcinoma in situ (DCIS), either with or without recurrence as invasive cancer, may be eligible to participate.
  • Study details: Participants will be required to provide medical history and undergo assessments to evaluate their DCIS condition. The study may involve collecting samples and other relevant information.
Print
Study details
    metastatic cancer

TX7992

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.